Loading...
OTCM
AEEYY
Market cap24mUSD
, Last price  
USD
Name

Willow Biosciences Inc

Chart & performance

D1W1MN
OTCM:AEEYY chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
33.73%
Rev. 5Y
299.45%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
-100.00%
00000000000016,9134,58410,000133,000821,0001,172,0004,662,0000
Net income
-3m
L-58.19%
-404,409-1,652,348-1,152,053-3,057,264-3,216,858-1,417,000-1,801,000-1,387,172-865,372-1,311,000-2,330,000-1,857,000-1,645,000-44,566,000-33,946,000-6,140,000-14,814,000-13,029,000-6,189,000-2,587,889
CFO
0
P
-211,791-1,105,101-922,612-889,158-865,764-564,695-96,042-921,187-614,451-433,340-1,280,663-537,685-1,333,084-9,161,395-12,780,000-18,227,000-13,862,000-10,920,000-3,723,0000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Atlas Energy Corp. is a biotechnology firm established in 2019 and headquartered in Calgary, Canada. The company specializes in the creation, manufacturing, and distribution of plant-based ingredients, primarily catering to the consumer care, food and beverage, and pharmaceutical industries throughout the United States. Atlas Energy Corp. maintains a strategic licensing and development partnership with Laurus Labs, focusing on the advancement and commercialization of active pharmaceutical ingredients and various other compounds. The company, previously known as Willow Biosciences Inc., officially adopted the name Atlas Energy Corp. in June 2025.

Key people

James Lalonde
Independent Chairman of the Board · since 2023
Mark Hodgson
President, Chief Executive Officer · since 2025
Travis Doupe
Chief Financial Officer · since 2025
Sanjib Gill
Corporate Secretary · since 2019
Al Foreman
Director · since 2023
Donald Archibald
Independent Director · since 2019
Raffi Asadorian
Independent Director · since 2023
URL
https://www.willowbio.com/
IPO date
Sep 14, 2017
Employees
32
Domiciled in
CA
Incorporated in
CA
Legal address
885 West Georgia Street
Suite 800
Vancouver, BC V6C 2G2
CA
Headquarters
701 Georgia Street West
Suite 1470
Vancouver, BC V7Y 1G5
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT